Occult atrial fibrillation in ischemic stroke
Seek and you shall find
Citation Manager Formats
Make Comment
See Comments
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Physicians frequently evaluate patients with recent ischemic strokes or transient ischemic attacks (TIA) and perform diagnostic evaluations only to find no clear demonstrable etiology in fully one-third of cases. Cryptogenic stroke remains a diagnostic category of exclusion and encompasses a broad range of patients with varied risk factors, comorbid conditions, and radiographic patterns of cerebral infarction. In contrast, atrial fibrillation (AF) is a common and well-defined cause of ischemic stroke, representing 50% of cardioembolic stroke and 10% of all ischemic strokes, often resulting in severe neurologic disability.1 AF can be readily diagnosed by electrocardiography, and has known risk factors, pathophysiology, and therapeutic options, including anticoagulation. Approximately 25% of patients with AF have intermittent AF that is often asymptomatic and undetected by conventional methods of brief cardiac telemetry monitoring.1,2 Patients who are initially diagnosed with cryptogenic stroke or TIA can be found subsequently to have intermittent AF, suggesting that efforts to improve AF detection are warranted. An optimal telemetry monitoring method for the detection of occult AF could identify stroke patients at risk for recurrent cardioembolic stroke and a subgroup that may benefit from anticoagulation.
Paroxysmal AF (PAF) is believed to carry the same stroke risk as continuous AF; however, patients with PAF exhibit a …
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Long-term Safety and Efficacy of Avalglucosidase Alfa in Patients With Late-Onset Pompe Disease
Dr. Marianne de Visser and Dr. Maudy Theunissen
► Watch
Related Articles
Topics Discussed
Alert Me
Recommended articles
-
Article
Predictors for atrial fibrillation detection after cryptogenic strokeResults from CRYSTAL AFVincent N. Thijs, Johannes Brachmann, Carlos A. Morillo et al.Neurology, December 18, 2015 -
Articles
Atrial fibrillation detected by mobile cardiac outpatient telemetry in cryptogenic TIA or strokeA. H. Tayal, M. Tian, K. M. Kelly et al.Neurology, September 24, 2008 -
Views & Reviews
Potential new uses of non–vitamin K antagonist oral anticoagulants to treat and prevent strokeShadi Yaghi, Hooman Kamel, Mitchell S.V. Elkind et al.Neurology, July 17, 2015 -
Resident and Fellow Section
Clinical Reasoning: An 87-year-old woman with left-sided numbnessShadi Yaghi, Mitchell S.V. Elkind et al.Neurology, October 12, 2015